Thursday, 29 October 2020

Gilead's revenue rises 17% driven by sales of coronavirus treatment remdesivir

Remdesivir generated $873 million in sales during the third quarter, mostly in the U.S., the company said.

from Earnings https://ift.tt/3e3SwI1
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)